TNSN99007A1 - Composition de mesylate de trovafloxacine et procede pour sa preparation - Google Patents

Composition de mesylate de trovafloxacine et procede pour sa preparation

Info

Publication number
TNSN99007A1
TNSN99007A1 TNTNSN99007A TNSN99007A TNSN99007A1 TN SN99007 A1 TNSN99007 A1 TN SN99007A1 TN TNSN99007 A TNTNSN99007 A TN TNSN99007A TN SN99007 A TNSN99007 A TN SN99007A TN SN99007 A1 TNSN99007 A1 TN SN99007A1
Authority
TN
Tunisia
Prior art keywords
preparation
trovafloxacin mesylate
mesylate composition
composition
compositions
Prior art date
Application number
TNTNSN99007A
Other languages
English (en)
Inventor
Dale Johnson Alton
Michael Sinko Christopher
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN99007A1 publication Critical patent/TNSN99007A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'INVENTION CONCERNE DES COMPOSITIONS, NOTAMMENT SOUS FORME DE COMPRIMES, CONTENANT LA FORME POLYMORPHE II DE MESYLATE DE TROVAFLOXACINE ET, EN OUTRE, UN LUBRIFIANT ET DE LA CELLULOSE MICROCRISTALLINE (CM) SERVANT DE DILUANT. ELLE CONCERNE EGALEMENT UN PROCEDE POUR LEUR PREPARATION. UTILISATION DE CES COMPOSITIONS POUR LE TRAITEMENT D'INFECTIONS BACTERIENNES.
TNTNSN99007A 1998-01-21 1999-01-20 Composition de mesylate de trovafloxacine et procede pour sa preparation TNSN99007A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
TNSN99007A1 true TNSN99007A1 (fr) 2005-11-10

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99007A TNSN99007A1 (fr) 1998-01-21 1999-01-20 Composition de mesylate de trovafloxacine et procede pour sa preparation

Country Status (34)

Country Link
US (1) US6187341B1 (fr)
EP (1) EP0930068A3 (fr)
JP (1) JPH11269072A (fr)
KR (1) KR100314977B1 (fr)
CN (1) CN1227743A (fr)
AP (1) AP1094A (fr)
AR (1) AR012780A1 (fr)
AU (1) AU758381B2 (fr)
BG (1) BG103106A (fr)
BR (1) BR9900116A (fr)
CA (1) CA2259698C (fr)
CO (1) CO4810225A1 (fr)
DZ (1) DZ2712A1 (fr)
EA (1) EA003247B1 (fr)
GT (1) GT199900004A (fr)
HR (1) HRP990023A2 (fr)
HU (1) HUP9900154A3 (fr)
ID (1) ID23735A (fr)
IL (1) IL128051A0 (fr)
IS (1) IS4947A (fr)
MA (1) MA24747A1 (fr)
NO (1) NO990243L (fr)
NZ (1) NZ333838A (fr)
OA (1) OA10958A (fr)
PA (1) PA8466701A1 (fr)
PE (1) PE20000169A1 (fr)
PL (1) PL330981A1 (fr)
SG (1) SG70666A1 (fr)
SK (1) SK4299A3 (fr)
TN (1) TNSN99007A1 (fr)
TR (1) TR199900089A2 (fr)
TW (1) TW518224B (fr)
YU (1) YU2399A (fr)
ZA (1) ZA99393B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142642A0 (en) * 1998-11-10 2002-03-10 Bayer Ag Pharmaceutical moxifloxacin preparation
CA2382834A1 (fr) * 1999-09-20 2001-03-29 Alza Corporation Procede destine a reduire la transformation polymorphique d'un medicament
IL148820A0 (en) * 1999-10-08 2002-09-12 Smithkline Beecham Corp Fab i inhibitors
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
WO2003088897A2 (fr) * 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Inhibiteurs de fab i
EP1396263A1 (fr) * 2002-08-09 2004-03-10 Warner-Lambert Company Compositions d'enrobage pour tablettes et caplets
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
EP1608377B1 (fr) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Compositions comportant plusieurs agents antibiotiques, et leurs procedes de mise en oeuvre
ES2297067T3 (es) * 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
MXPA06000702A (es) * 2003-07-23 2006-04-11 Perrigo L Co Composicion que contiene fibra celulosica.
JP5087406B2 (ja) 2004-06-04 2012-12-05 アフィニウム ファーマシューティカルズ， インク． 治療薬ならびにその製造方法および使用方法
EP1809259B1 (fr) * 2004-10-15 2014-12-03 Supernus Pharmaceuticals, Inc. Preparations pharmaceutiques pour lesquelles le risque d'abus est reduit
JP2009518399A (ja) * 2005-12-05 2009-05-07 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉ阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
WO2008009122A1 (fr) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Dérivés d'acrylamide en tant qu'inhibiteurs de fab i
WO2008098374A1 (fr) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
DK2861608T3 (da) 2012-06-19 2019-06-24 Debiopharm Int Sa Prodrug-derivater af (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamid
CN108778286A (zh) 2016-02-26 2018-11-09 德彪药业国际股份公司 用于治疗糖尿病足感染的药物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
CA2229786C (fr) * 1995-08-29 2002-02-19 David Bruning Joseph Formes zwitterioniques de trovafloxacine

Also Published As

Publication number Publication date
EA003247B1 (ru) 2003-02-27
ID23735A (id) 2000-05-11
KR19990068014A (ko) 1999-08-25
PL330981A1 (en) 1999-08-02
IL128051A0 (en) 1999-11-30
ZA99393B (en) 2000-07-21
CA2259698A1 (fr) 1999-07-21
MA24747A1 (fr) 1999-10-01
HUP9900154A3 (en) 2000-12-28
EP0930068A3 (fr) 1999-12-22
BG103106A (en) 1999-08-31
DZ2712A1 (fr) 2003-09-01
CO4810225A1 (es) 1999-06-30
AP1094A (en) 2002-08-19
PA8466701A1 (es) 2000-09-29
AU1217399A (en) 1999-08-12
AP9901443A0 (en) 1999-03-31
OA10958A (en) 2001-10-31
SK4299A3 (en) 2000-06-12
HUP9900154A2 (hu) 1999-09-28
US6187341B1 (en) 2001-02-13
SG70666A1 (en) 2000-02-22
YU2399A (sh) 2002-06-19
GT199900004A (es) 2000-07-08
TR199900089A3 (tr) 1999-10-21
NO990243D0 (no) 1999-01-20
TW518224B (en) 2003-01-21
NZ333838A (en) 2000-03-27
IS4947A (is) 1999-07-22
HU9900154D0 (en) 1999-03-29
EA199900046A3 (ru) 1999-12-29
EP0930068A2 (fr) 1999-07-21
KR100314977B1 (ko) 2001-11-24
PE20000169A1 (es) 2000-03-10
NO990243L (no) 1999-07-22
AU758381B2 (en) 2003-03-20
JPH11269072A (ja) 1999-10-05
HRP990023A2 (en) 1999-08-31
TR199900089A2 (xx) 1999-10-21
AR012780A1 (es) 2000-11-08
BR9900116A (pt) 2000-05-02
CN1227743A (zh) 1999-09-08
CA2259698C (fr) 2003-04-15
EA199900046A2 (ru) 1999-08-26

Similar Documents

Publication Publication Date Title
TNSN99007A1 (fr) Composition de mesylate de trovafloxacine et procede pour sa preparation
TNSN99126A1 (fr) Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99170A1 (fr) Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98182A1 (fr) Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98238A1 (fr) Macrolides nouveaux
TNSN00007A1 (fr) Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99073A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26720A1 (fr) Composes nouveaux inhibiteurs de reabsorption de monoamines, procede pour leur preparation, et compositions pharmaceutiques les contenant.
TNSN99006A1 (fr) 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN01017A1 (fr) Compositions comprenant un antibiotique azalide, et procedes pour leur preparation
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99236A1 (fr) Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99125A1 (fr) Pyrrolo(2,3-d) pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780403B3 (fr) Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
TNSN99053A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
TNSN99142A1 (fr) Derives de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procede pour leur preparation.
TNSN99110A1 (fr) Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
CH689805A8 (fr) Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
TNSN99214A1 (fr) Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99031A1 (fr) Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99198A1 (fr) PYRAZOLOPYRIMIDINONES NOUVELLES INHIBITRICES DE PDE-5 GMPc, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
TNSN01046A1 (fr) Ethers de diphenyle utiles en therapeutique
TNSN00250A1 (fr) Composes nouveaux inhibiteurs de pcp, procede pour leur preparation et compositions les contenant
TNSN99221A1 (fr) Derive d'indole nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant